Aditxt, Inc. (ADTX) vs Lunai Bioworks Inc. (LNAI)

Aditxt, Inc. and Lunai Bioworks Inc. are both Biotechnology companies. Aditxt, Inc. and Lunai Bioworks Inc. are of similar size ($4.4M and $4.2M). Lunai Bioworks Inc. has the higher net margin (−3,761.9% vs −372,998.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Lunai Bioworks Inc. leads on 7 and Aditxt, Inc. on 5.

Valuation

Metric ADTX LNAI Biotechnology median
P/E n/m n/m 8.50
P/S n/m 24.13 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 73.26 18.71 9.21
Earnings yield 0.00% (150.78%) (33.15%)
Free cash flow yield 0.00% (232.47%) (25.50%)

Profitability

Metric ADTX LNAI Biotechnology median
Gross margin 20.28% (3.48%) 65.16%
Operating margin (128,143.36%) (9,184.79%) 0.00%
Net margin (372,998.60%) (3,761.88%) 0.00%
Free cash flow margin (129,979.72%) (5,610.24%) 0.00%
Return on equity 549.59% 23.46% (56.36%)
Return on assets (236.38%) (39.21%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ADTX LNAI Biotechnology median
Revenue growth (TTM) (74.19%) — 6.02%
EPS growth (last fiscal year) (918.27%) 98.77% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADTX LNAI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.06 0.11 4.72
Net debt to EBITDA 0.18 0.20 0.96

Dividend

Metric ADTX LNAI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ADTX LNAI Biotechnology median
Market cap 4.39m 4.15m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack